相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Epithelial disruption drives mesendoderm differentiation in human pluripotent stem cells by enabling TGF-β protein sensing
Thomas Legier et al.
NATURE COMMUNICATIONS (2023)
Phospholipid Scramblases: Role in Cancer Progression and Anticancer Therapeutics
Himadri Gourav Behuria et al.
FRONTIERS IN GENETICS (2022)
Pan-Cancer Analysis Based on EPOR Expression With Potential Value in Prognosis and Tumor Immunity in 33 Tumors
Yajing Zhang et al.
FRONTIERS IN ONCOLOGY (2022)
The Latest Evidence of Erythropoietin in the Treatment of Glaucoma
Ting-Yi Lin et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Erythropoietin-driven dynamic proteome adaptations during erythropoiesis prevent iron overload in the developing embryo
Sajib Chakraborty et al.
CELL REPORTS (2022)
Variation in colectomy rates for benign polyp and colorectal cancer
Joceline V. Vu et al.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2021)
IGFBP7-AS1 is a p53-responsive long noncoding RNA downregulated by Epstein-Barr virus that contributes to viral tumorigenesis
Wei Dang et al.
CANCER LETTERS (2021)
Downregulation of SFRP2 facilitates cancer stemness and radioresistance of glioma cells via activating Wnt/β-catenin signaling
Quansheng Wu et al.
PLOS ONE (2021)
EpoR stimulates rapid cycling and larger red cells during mouse and human erythropoiesis
Daniel Hidalgo et al.
NATURE COMMUNICATIONS (2021)
EFNB1 Acts as a Novel Prognosis Marker in Glioblastoma through Bioinformatics Methods and Experimental Validation
Yaohong Shi et al.
JOURNAL OF ONCOLOGY (2021)
STAT5 as a Key Protein of Erythropoietin Signalization
Zuzana Tothova et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
The Role of PI3K/AKT and MAPK Signaling Pathways in Erythropoietin Signalization
Zuzana Tothova et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
STAT5a Confers Doxorubicin Resistance to Breast Cancer by Regulating ABCB1
Zhaoqing Li et al.
FRONTIERS IN ONCOLOGY (2021)
Claudin-1, A Double-Edged Sword in Cancer
Ajaz A. Bhat et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Downregulation of glypican-4 facilitates breast cancer progression by inducing cell migration and proliferation
Javaria Munir et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
Phospho-proteomic discovery of novel signal transducers including thioredoxin-interacting protein as mediators of erythropoietin-dependent human erythropoiesis
Matthew A. Held et al.
EXPERIMENTAL HEMATOLOGY (2020)
Hypoxanthine Phosphoribosyl Transferase 1 Is Upregulated, Predicts Clinical Outcome and Controls Gene Expression in Breast Cancer
Melina J. Sedano et al.
CANCERS (2020)
Metabolic Reprogramming of Chemoresistant Cancer Cells and the Potential Significance of Metabolic Regulation in the Reversal of Cancer Chemoresistance
Xun Chen et al.
METABOLITES (2020)
RNA interference-mediated downregulation of phospholipid scramblase 1 expression in primary liver cancer in vitro
Liang Gui et al.
ONCOLOGY LETTERS (2020)
Signaling Through the Erythropoietin Receptor Affects Angiogenesis in Retinovascular Disease
Colin A. Bretz et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2020)
The Expression, Regulation, and Biomarker Potential of Glypican-1 in Cancer
Sen Wang et al.
FRONTIERS IN ONCOLOGY (2019)
The Multifaceted p21 (Cip1/Waf1/CDKN1A) in Cell Differentiation, Migration and Cancer Therapy
Nina-Naomi Kreis et al.
CANCERS (2019)
Modulation of TGFβ/Smad signaling by the small GTPase RhoB
Melina Livitsanou et al.
CELLULAR SIGNALLING (2018)
Loss of of c-KIT expression in breast cancer correlates with malignant transformation of breast epithelium and is mediated by KIT gene promoter DNA hypermethylation
Radoslav Janostiak et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2018)
Synuclein gamma expression enhances radiation resistance of breast cancer cells
Lu Tian et al.
Oncotarget (2018)
Alternative Erythropoietin Receptors in the Nervous System
Daniela Ostrowski et al.
JOURNAL OF CLINICAL MEDICINE (2018)
Cytoplasmic p21 Mediates 5-Fluorouracil Resistance by Inhibiting Pro-Apoptotic Chk2
Arnatchai Maiuthed et al.
CANCERS (2018)
Overexpression of the erythropoietin receptor in RAMA 37 breast cancer cells alters cell growth and sensitivity to tamoxifen
Lenka Ilkovicova et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
p21: A Two-Faced Genome Guardian
Alexandros G. Georgakilas et al.
TRENDS IN MOLECULAR MEDICINE (2017)
Erythropoietin drives breast cancer progression by activation of its receptor EPOR
Ka Kui Chan et al.
ONCOTARGET (2017)
Xanthine dehydrogenase downregulation promotes TGFβ signaling and cancer stem cell-related gene expression in hepatocellular carcinoma
G-L Chen et al.
ONCOGENESIS (2017)
The Erythropoietin System Protects the Heart Upon Injury by Cardiac Progenitor Cell Activation
Maria P. Zafeiriou
ERYTHROPOIETIN (2017)
Erythropoietin in bone - Controversies and consensus
Sahar Hiram-Bab et al.
CYTOKINE (2017)
RhoB upregulation leads to either apoptosis or cytostasis through differential target selection
Laura A. Marlow et al.
ENDOCRINE-RELATED CANCER (2015)
Tumor suppressive microRNA-200a inhibits renal cell carcinoma development by directly targeting TGFB2
Ruijing Lu et al.
TUMOR BIOLOGY (2015)
CYP1B1 enhances the resistance of epithelial ovarian cancer cells to paclitaxel in vivo and in vitro
Zhuangyan Zhu et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2015)
Erythropoietin and the heart: Physiological effects and the therapeutic perspective
Fabian Sanchis-Gomar et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2014)
Erythropoietin Action in Stress Response, Tissue Maintenance and Metabolism
Yuanyuan Zhang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Association between epidermal growth factor receptor gene copy number and ERCC1, BRCA1 protein expression in Chinese patients with non-small cell lung cancer
Yalei Zhang et al.
MEDICAL ONCOLOGY (2014)
The role of aldehyde dehydrogenase (ALDH) in cancer drug resistance
Radoslaw Januchowski et al.
BIOMEDICINE & PHARMACOTHERAPY (2013)
Unphosphorylated STAT5A stabilizes heterochromatin and suppresses tumor growth
Xiaoyu Hu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Cytoplasmic translocation of p21 mediates NUPR1-induced chemoresistance NUPR1 and p21 in chemoresistance
Andrew J. Vincent et al.
FEBS LETTERS (2012)
Erythropoietin Receptor Signaling Is Membrane Raft Dependent
Kathy L. McGraw et al.
PLOS ONE (2012)
Defining an EPOR- Regulated Transcriptome for Primary Progenitors, including Tnfr-sf13c as a Novel Mediator of EPO- Dependent Erythroblast Formation
Seema Singh et al.
PLOS ONE (2012)
Cytoplasmic p21 is a potential predictor for cisplatin sensitivity in ovarian cancer
Xi Xia et al.
BMC CANCER (2011)
Fine-tuning of cell signaling by glypicans
A. Fico et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2011)
IGFBP7 is a p53 target gene inactivated in human lung cancer by DNA hypermethylation
Yuan Chen et al.
LUNG CANCER (2011)
IGFBP7 is a p53-responsive gene specifically silenced in colorectal cancer with CpG island methylator phenotype
Hiromu Suzuki et al.
CARCINOGENESIS (2010)
Cytoplasmic p21 expression levels determine cisplatin resistance in human testicular cancer
Roelof Koster et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Erythropoietin-Induced Activation of the JAK2/STAT5, PI3K/Akt, and Ras/ERK Pathways Promotes Malignant Cell Behavior in a Modified Breast Cancer Cell Line
Zhanzhong Shi et al.
MOLECULAR CANCER RESEARCH (2010)
Over-expression of EphB3 enhances cell-cell contacts and suppresses tumor growth in HT-29 human colon cancer cells
Sou-Tyau Chiu et al.
CARCINOGENESIS (2009)
Evaluating Erythropoietin-Associated Tumor Progression Using Archival Tissues from a Phase III Clinical Trial
Chris P. Miller et al.
STEM CELLS (2009)
Erythropoietin: New approaches to improved molecular designs and therapeutic alternatives
N. Debeljak et al.
CURRENT PHARMACEUTICAL DESIGN (2008)
JAK2/STAT2/STAT3 Are Required for Myogenic Differentiation
Kepeng Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Association between Pak1 expression and subcellular localization and tamoxifen resistance in breast cancer patients
Caroline Holm et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Autocrine/paracrine secreted Frizzled-related protein 2 induces cellular resistance to apoptosis - A possible mechanism of mammary tumorigenesis
JL Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Eph/ephrin signaling in morphogenesis, neural development and plasticity
R Klein
CURRENT OPINION IN CELL BIOLOGY (2004)
Smad-dependent and Smad-independent pathways in TGF-β family signalling
R Derynck et al.
NATURE (2003)
Eph/Ephrin signaling regulates the mesenchymal-to-epithelial transition of the paraxial mesoderm during somite morphogenesis
A Barrios et al.
CURRENT BIOLOGY (2003)
Paclitaxel increases p21 synthesis and accumulation of its AKT-phosphorylated form in the cytoplasm of cancer cells
C Héliez et al.
ONCOGENE (2003)
AKT/PKB phosphorylation of p21Cip/WAF1 enhances protein stability of p21Cip/WAF1 and promotes cell survival
Y Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress
AL Sirén et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Transcriptional suppression of synuclein γ (SNCG) expression in human breast cancer cells by the growth inhibitory cytokine oncostatin M
JW Liu et al.
BREAST CANCER RESEARCH AND TREATMENT (2000)